Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Tanja Štular - , National Institute of Chemistry Ljubljana (Author)
  • Samo Lešnik - , National Institute of Chemistry Ljubljana (Author)
  • Kaja Rožman - , University of Ljubljana (Author)
  • Julia Schink - , University of Primorska (Author)
  • Mitja Zdouc - , University of Primorska (Author)
  • An Ghysels - , Ghent University Hospital (Author)
  • Feng Liu - , AAT Bioquest (Author)
  • Courtney C Aldrich - , University of Minnesota System (Author)
  • V Joachim Haupt - , Biotechnology Center (BIOTEC) (Author)
  • Sebastian Salentin - , Biotechnology Center, Faculty of Computer Sciences, Chair of Bioinformatics (Author)
  • Simone Daminelli - , Biotechnology Center, Chair of Bioinformatics (Author)
  • Michael Schroeder - , Biotechnology Center, Chair of Bioinformatics (Author)
  • Thierry Langer - , University Hospital Vienna (Author)
  • Stanislav Gobec - , University of Ljubljana (Author)
  • Dušanka Janežič - , University of Primorska (Author)
  • Janez Konc - , National Institute of Chemistry Ljubljana (Author)

Abstract

Drug discovery is usually focused on a single protein target; in this process, existing compounds that bind to related proteins are often ignored. We describe ProBiS plugin, extension of our earlier ProBiS-ligands approach, which for a given protein structure allows prediction of its binding sites and, for each binding site, the ligands from similar binding sites in the Protein Data Bank. We developed a new database of precalculated binding site comparisons of about 290000 proteins to allow fast prediction of binding sites in existing proteins. The plugin enables advanced viewing of predicted binding sites, ligands' poses, and their interactions in three-dimensional graphics. Using the InhA query protein, an enoyl reductase enzyme in the Mycobacterium tuberculosis fatty acid biosynthesis pathway, we predicted its possible ligands and assessed their inhibitory activity experimentally. This resulted in three previously unrecognized inhibitors with novel scaffolds, demonstrating the plugin's utility in the early drug discovery process.

Details

Original languageEnglish
Pages (from-to)11069-11078
Number of pages10
JournalJournal of medicinal chemistry
Volume59
Issue number24
Publication statusPublished - 29 Nov 2016
Peer-reviewedYes

External IDs

PubMedCentral PMC5588031
Scopus 85007155054
ORCID /0000-0003-2848-6949/work/141543371

Keywords

Sustainable Development Goals

Keywords

  • Bacterial Proteins/antagonists & inhibitors, Binding Sites/drug effects, Dose-Response Relationship, Drug, Drug Discovery, Fatty Acids/biosynthesis, Ligands, Models, Molecular, Molecular Structure, Mycobacterium tuberculosis/enzymology, Oxidoreductases/antagonists & inhibitors, Structure-Activity Relationship